Navigation Links
Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results
Date:8/1/2014

ght patients, subject to regulatory approval of BELVIQ by the State of Israel Ministry of Health.
  • Arena and Eisai participated at the American Diabetes Association's 74th Scientific Sessions in San Francisco, California, including giving one oral presentation, Lorcaserin Can Improve Weight Loss in Patients with Prediabetes and Reduce Progression to Diabetes in Obese and Overweight Patients, and presenting two posters, Change in A1C in Overweight Patients with Type 2 Diabetes with the Healthy Lifestyle Program Used in the Lorcaserin Phase 3 Trials and Lorcaserin Free Plasma Levels at Recommended Dose are Sufficient to Activate Serotonin 2C but not 2A or 2B Receptors.
  • An article based on post-hoc analyses from the three pivotal Phase 3 trials of lorcaserin entitled, "Early Weight Loss While on Lorcaserin, Diet, and Exercise as a Predictor of Week 52 Weight-Loss Outcomes," was published in the online issue of Obesity, the official peer reviewed journal of The Obesity Society.
  • BELVIQ was nominated by the Galien Foundation and Awards Committee for the 2014 Prix Galien USA Award in the Best Pharmaceutical Agent category.
  • Research & Development

  • Arena and Eisai completed enrollment of a 12-week, Phase 2, proof-of-concept trial of approximately 600 active smokers to evaluate lorcaserin as an aid to smoking cessation, and completed enrollment in a pilot study of approximately 225 patients to evaluate the safety of co-administration of lorcaserin with phentermine. Results are expected for both of these studies around the end of the year.
  • Arena initiated dosing in a Phase 1 multiple-ascending dose trial of APD334, a novel, oral drug candidate that targets the sphingosine 1-phosphate subtype 1 (S1P1) receptor, to evaluate the compound for the treatment of a number of autoimmune diseases.
  • Arena was granted US Patent No. 8,778,950, entitled
    '/>"/>

  • SOURCE Arena Pharmaceuticals, Inc.
    Copyright©2014 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11

    Related medicine technology :

    1. Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity
    2. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1
    3. Healthcare Companies Announce Drug Launches, Upcoming Conference Calls, and Financial Results Schedules - Research Report on Bristol-Myers Squibb, Teva, Jazz, AmerisourceBergen and Arena
    4. Arena Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference
    5. Arena Pharmaceuticals to Present at the 25th Annual Piper Jaffray Healthcare Conference
    6. Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2013 Financial Results
    7. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, November 7
    8. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
    9. Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch Global Healthcare Conference
    10. Arena Pharmaceuticals Completes Phase 1b Clinical Trial Evaluating APD811 for Pulmonary Arterial Hypertension
    11. Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2013 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/3/2015)... , July 4, 2015 ... cible les épidémies que sont l,hypertension, le diabète ... du Sud-Est, par l,intermédiaire de plateformes éducatives gratuites ...      (Photo: http://photos.prnewswire.com/prnh/20150630/227090 ) ... charge le diabète en ligne , Prendre ...
    (Date:7/3/2015)... 2015 According to a ... Rhythm Management Market ECG, Implantable Loop Recorder, Manual ... Defibrillator, Dual Chamber Pacemaker, CRT-D, CRT-P - Global ... Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) ... by 2020 from $21,137.7 Million in 2015, at ...
    (Date:7/3/2015)... , July 3, 2015 ... epidemics of hypertension, diabetes and thyroid disorders in ... platforms and a major conference dedicated to these diseases. ... Manage Diabetes Online , Manage Hypertension Online ... and operated by EXCEMED - combine the ...
    Breaking Medicine Technology:Lutter contre trois maladies chroniques majeures en Asie centrale et du Sud-Est grâce à la formation médicale 2Lutter contre trois maladies chroniques majeures en Asie centrale et du Sud-Est grâce à la formation médicale 3Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 2Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 3Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 4Combating Three Major Chronic Diseases in Latin America With Medical Education 2
    ... , PITTSBURGH , June 29 Mylan Inc. (Nasdaq: ... received final approval from the U.S. Food and Drug Administration (FDA) for ... generic version of AstraZeneca,s Arimidex® Tablets, a treatment for early breast cancer. ... Anastrozole Tablets had U.S. ...
    ... , ORLANDO, Fla. and CARLSBAD, Calif. , ... ISIS ) announced today that data from seven programs in ... Diabetes Association,s (ADA) 70th Scientific Sessions in Orlando . ... Phase 2 study of ISIS 113715 in patients with type ...
    Cached Medicine Technology:Mylan Receives Approval for Generic Version of Arimidex® Tablets 2Isis Highlights New Data on Antisense Drugs to Treat Type 2 Diabetes and Obesity From Its Broad Metabolic Disease Franchise at ADA Scientific Sessions 2Isis Highlights New Data on Antisense Drugs to Treat Type 2 Diabetes and Obesity From Its Broad Metabolic Disease Franchise at ADA Scientific Sessions 3Isis Highlights New Data on Antisense Drugs to Treat Type 2 Diabetes and Obesity From Its Broad Metabolic Disease Franchise at ADA Scientific Sessions 4Isis Highlights New Data on Antisense Drugs to Treat Type 2 Diabetes and Obesity From Its Broad Metabolic Disease Franchise at ADA Scientific Sessions 5Isis Highlights New Data on Antisense Drugs to Treat Type 2 Diabetes and Obesity From Its Broad Metabolic Disease Franchise at ADA Scientific Sessions 6Isis Highlights New Data on Antisense Drugs to Treat Type 2 Diabetes and Obesity From Its Broad Metabolic Disease Franchise at ADA Scientific Sessions 7Isis Highlights New Data on Antisense Drugs to Treat Type 2 Diabetes and Obesity From Its Broad Metabolic Disease Franchise at ADA Scientific Sessions 8
    (Date:7/5/2015)... ... ... Women’s Excellence in Wellness, powered by Movestrong is offering a student special (high ... of unlimited classes for just $65. Student ID is needed at registration. , Women's ... Lake Orion. , Women’s Excellence is the most comprehensive obstetric and ...
    (Date:7/4/2015)... ... July 04, 2015 , ... When a hacker gains access to someone’s email account, it can ... On Wednesday, July 1st, the FTC issued a scam alert about a social engineering ... process for a password reset instigated by the hacker. All they have to do ...
    (Date:7/3/2015)... (PRWEB) , ... July 03, ... ... announced the sessions and speaker lineup for its 2015 Annual Conference ... place August 6-8, 2015 at the Renaissance Orlando at SeaWorld in Orlando, ...
    (Date:7/3/2015)... ... July 03, 2015 , ... The Erie County Bar Association ... 1:00pm. The Association welcomed speaker C. Daniel McGillicuddy Esq. of William Mattar Law ... of investigating these types of cases. , Each year, New York State residents ...
    (Date:7/3/2015)... ... ... " Selfie on a Stick ” was featured on NewsWatch as part of ... consumers. Amanda Forstrom, a technology expert and special reporter for NewsWatch, conducted the review ... Almost every smartphone has an incredibly powerful camera built into it. And when someone ...
    Breaking Medicine News(10 mins):Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 2Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 3Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 4Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 2Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 3Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2Health News:Learn How to Take Selfies like Kendall Jenner 2
    ... money and an equally aged caregiver sister who is suffering from cancer. ... cannot be left safely on her own, forcing her son to cut ... A 78-year-old Los Angeles man with Alzheimer,s whose daughter will have ... services are cut. These are some of the ...
    ... remains a mystery, , THURSDAY, Oct. 1 (HealthDay News) -- ... still in their mother,s womb were about 20 percent more ... study has found. , The flu outbreak in 1918 killed ... the United States. That flu, like the current H1N1 swine ...
    ... ... Mining will be held from November 16-18, 2009 in New York, NY. This three-day conference ... and international harmonization initiatives. , ... Horsham, PA (PRWEB) October 1, 2009 -- The 2nd DIA Conference on Signal ...
    ... Calif., Oct. 1 Cynthia Perkins, M.Ed., publishes new ... Alcoholism , to provide alcoholics with the little known ... Sober Stay Sober: The Truth About Alcoholism provides ... alcoholism and its successful treatment! Despite past decades of ...
    ... LA JOLLA, CA September 30, 2009 Researchers at ... characterized a poorly defined component of a key molecular ... also helps cancer cells resist chemotherapy. The research ... the journal Cell . This biological machinethe ...
    ... Va.SNM is collaborating with the International Partnership for Critical ... and Surrogate Endpoints Symposium, Bethesda North Marriott Hotel and ... session, co-hosted by SNM and CMOD, will be held ... p.m. "We are pleased to further extend ...
    Cached Medicine News:Health News:Half-million low-income elderly affected by sweeping cuts to state safety net 2Health News:Half-million low-income elderly affected by sweeping cuts to state safety net 3Health News:Pre-Birth Exposure to 1918 Flu Raised Heart Risks, Study Finds 2Health News:Pre-Birth Exposure to 1918 Flu Raised Heart Risks, Study Finds 3Health News:International Experts to Review State-of-the-Art Thinking on Signal Detection and Data Mining 2Health News:International Experts to Review State-of-the-Art Thinking on Signal Detection and Data Mining 3Health News:New Book Provides Alcoholics with Hope for Stable, Long-Term, Craving-Free Sobriety 2Health News:Scripps research scientists find missing puzzle piece of powerful DNA repair complex 2Health News:Scripps research scientists find missing puzzle piece of powerful DNA repair complex 3Health News:Scripps research scientists find missing puzzle piece of powerful DNA repair complex 4Health News:Meeting highlights the role of molecular imaging biomarkers in clinical research and therapeutics 2
    Kit Nebulizer Small Volume Medication W/Pediatric Mask Mouthpiece 7FT O 2 Tubing...
    ... Nebulizer Small Volume Medication W/Adult Mask PT ... Tee Adapter , ,An advanced ... ,Provide fine particles with a tighter ... conventional nebulizers, ,Our AirLife™ brand Misty ...
    Nebulizer Custom Kit...
    ... Respiratory Products, ,Westmed designs, manufacturers and ... and Respiratory professionals. Our mission is to ... clinician's ability to deliver quality medical care ... line. , ,Our web site is ...
    Medicine Products: